Price
Financials
Consolidated, Rs crore| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 99.20 | 128.58 | 115.66 | 161.59 | 145.26 | 168.87 | 168.01 | 220.92 | 174.42 |
| Expenses | 97.12 | 115.53 | 107.69 | 145.66 | 134.22 | 159.66 | 157.14 | 200.72 | 158.52 |
| Operating Profit | 2.08 | 13.05 | 7.97 | 15.93 | 11.04 | 9.21 | 10.87 | 20.20 | 15.90 |
| OPM % | 2.10% | 10.15% | 6.89% | 9.86% | 7.60% | 5.45% | 6.47% | 9.14% | 9.12% |
| Other Income | 0.98 | -0.85 | 0.51 | -0.81 | 1.21 | 1.86 | 1.52 | 4.13 | 1.22 |
| Interest | 3.94 | 3.70 | 4.00 | 4.40 | 5.96 | 5.94 | 6.28 | 7.53 | 8.21 |
| Depreciation | 0.67 | 0.67 | 0.63 | 0.83 | 0.88 | 0.90 | 0.91 | 1.09 | 1.41 |
| Profit before tax | -1.55 | 7.83 | 3.85 | 9.89 | 5.41 | 4.23 | 5.20 | 15.71 | 7.50 |
| Tax % | -21.94% | 24.90% | 24.94% | 25.08% | 26.80% | 8.51% | 20.19% | 27.43% | 25.33% |
| Net Profit | -1.21 | 5.88 | 2.88 | 7.41 | 3.96 | 3.87 | 4.15 | 11.40 | 5.61 |
| EPS in Rs | -0.05 | 0.24 | 0.12 | 0.31 | 0.17 | 0.17 | 0.18 | 0.45 | 0.23 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 148 | 193 | 357 | 461 | 464 | 505 | 703 | 732 |
| Expenses | 143 | 186 | 346 | 446 | 441 | 465 | 652 | 676 |
| Operating Profit | 5 | 7 | 11 | 15 | 23 | 40 | 51 | 56 |
| OPM % | 3.2% | 3.7% | 3.1% | 3.2% | 4.9% | 8% | 7% | 8% |
| Other Income | 0 | 0 | 0 | 1 | 3 | -0 | 9 | 9 |
| Interest | 3 | 3 | 3 | 5 | 9 | 16 | 26 | 28 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 2 | 4 | 4 |
| Profit before tax | 2 | 4 | 7 | 9 | 15 | 22 | 31 | 33 |
| Tax % | 26% | 25% | 26% | 26% | 25% | 26% | 23% | |
| Net Profit | 1 | 3 | 5 | 7 | 11 | 16 | 23 | 25 |
| EPS in Rs | 0.13 | 0.28 | 0.54 | 0.29 | 0.48 | 0.66 | 0.97 | 1.03 |
| Dividend Payout % | 0% | 0% | 0% | 10% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 29% | 15% | 33% | ||
| Compounded Profit Growth | % | 54% | 48% | 13% | ||
| Stock Price CAGR | % | % | 64% | 44% | ||
| Return on Equity | % | 14% | 14% | 16% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 24 | 24 | 24 | 24 |
| Reserves | 10 | 13 | 20 | 77 | 88 | 107 | 131 |
| Borrowings | 21 | 30 | 31 | 34 | 105 | 171 | 285 |
| Other Liabilities | 18 | 47 | 77 | 97 | 67 | 100 | 202 |
| Total Liabilities | 58 | 99 | 138 | 232 | 283 | 402 | 642 |
| Fixed Assets | 6 | 6 | 6 | 20 | 26 | 24 | 104 |
| CWIP | 0 | 0 | 1 | 0 | 2 | 6 | 3 |
| Investments | 0 | 0 | 0 | 12 | 14 | 30 | 0 |
| Other Assets | 53 | 93 | 131 | 200 | 242 | 342 | 534 |
| Total Assets | 58 | 99 | 138 | 232 | 283 | 402 | 642 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1 | 3 | -4 | -29 | 6 | 35 | -2 |
| Cash from Investing Activity | -3 | -1 | -1 | -26 | -5 | -20 | -78 |
| Cash from Financing Activity | -0 | -1 | 4 | 66 | -12 | -14 | 79 |
| Net Cash Flow | -2 | -0 | -1 | 11 | -12 | 0 | -1 |
| Free Cash Flow | -4 | 1 | -5 | -43 | 2 | 30 | -51 |
| CFO/OP | 20% | 50% | -19% | -179% | 36% | 96% | 7% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 114 | 75 | 64 | 96 | 116 | 121 |
| Inventory Days | 46 | 49 | 51 | 63 | 74 | 117 | 129 |
| Days Payable | 40 | 91 | 80 | 78 | 49 | 76 | 111 |
| Cash Conversion Cycle | 72 | 72 | 46 | 50 | 122 | 156 | 139 |
| Working Capital Days | 35 | 29 | 27 | 54 | 62 | 53 | 17 |
| ROCE % | 15% | 19% | 15% | 14% | 16% | 15% |
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Aug 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 58.93% | 58.93% |
| FIIs | 3.58% | 1.40% | 1.40% | 13.07% | 18.45% | 19.49% | 20.79% | 19.78% | 19.95% | 19.38% | 19.88% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 39.02% | 41.20% | 41.21% | 29.54% | 24.16% | 23.07% | 21.76% | 22.79% | 22.61% | 21.65% | 21.15% |
| No. of Shareholders | 1,244 | 983 | 913 | 787 | 1,212 | 1,327 | 1,383 | 1,407 | 1,346 | 1,231 | 1,217 |
Fundamentals
Market Cap₹ 933 Cr.
Current Price₹ 37.4
Stock P/E37.1
Book Value₹ 6.44
ROCE15.1 %
ROE16.3 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)33%
Compounded Profit Growth (TTM)13%
Consolidated figures.
Valuation
Market capRs 930 Cr
Enterprise valueRs 952 Cr
P/E (TTM)39.89x
Price to book9.21x
Price to sales1.32x
EV / EBITDA15.86x
EV / EBIT16.92x
EV / sales1.35x
Earnings yield2.51%
Dividend yield0.08%
P/E, 3-year average1.91x
P/B, 3-year average0.13x
Profitability
Operating margin (excl. other income)3.23%
Operating margin (incl. other income)3.42%
EBITDA margin8.54%
Pre-tax margin4.35%
Net profit margin3.32%
Net margin, latest quarter4.86%
ROE10.77%
ROCE15.24%
ROA3.81%
ROE, 3-year average14.49%
ROCE, 3-year average16.18%
ROA, 3-year average3.88%
ROIC (approx.)33.78%
Tax rate25.92%
Other income / net worth0.87%
Growth
Sales growth (latest year)29.19%
Profit growth (latest year)34.10%
Sales CAGR, 3 years46.08%
Profit CAGR, 3 years76.52%
Sales growth QoQ31.49%
Profit growth QoQ146.10%
Sales growth YoY (latest quarter)36.72%
Profit growth YoY (latest quarter)44.80%
Per share
EPS (TTM)Rs 0.93
EPS (latest year)Rs 2.93
EPS (latest quarter)Rs 0.43
EPS, 3-year averageRs 3.68
Book value per shareRs 4.04
Sales per shareRs 28.16
Cash flow per shareRs -1.15
Free cash flow per shareRs -2.04
Dividend per share (latest year)Rs 0.30
Dividend per share, 3-year averageRs 0.30
Dividends
Dividend payout10.23%
Dividend payout, 3-year average10.23%
Efficiency
Asset turnover1.98x
Fixed asset turnover23.19x
Inventory turnover5.89x
Inventory days62 days
Debtor days64 days
Debtors turnover5.66x
Creditor days111 days
Cash conversion cycle139 days
Working capital days17 days
Leverage
Total debtRs 34 Cr
Cash and bankRs 12 Cr
Net debtRs 22 Cr
Debt to equity0.34x
Net debt / EBITDA0.37x
Interest coverage2.19x
Owners' fund to total sources43.44%
Debt to assets14.67%
Cash flow
Cash from Operating Activity (latest year)Rs -29 Cr
Cash from Investing Activity (latest year)Rs -26 Cr
Cash from Financing Activity (latest year)Rs 66 Cr
Net Cash Flow (latest year)Rs 11 Cr
Free cash flow (latest year)Rs -51 Cr
FCFE (approx.: FCF + change in debt)Rs -48 Cr
Cash from ops / profit, 5 years0.10x
Statement figures
Net sales (TTM)Rs 703 Cr
Net sales (latest year)Rs 461 Cr
Sales (latest quarter)Rs 221 Cr
Operating profit excl. other income (latest year)Rs 15 Cr
Operating profit (latest quarter)Rs 20 Cr
Other income (TTM)Rs 9 Cr
EBITDA (TTM)Rs 60 Cr
PBDT (TTM)Rs 34 Cr
Profit before tax (TTM)Rs 31 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 23 Cr
Net profit (latest year)Rs 7 Cr
Net profit (latest quarter)Rs 11 Cr
Depreciation (TTM)Rs 4 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 26 Cr
Cost of goods sold (latest year)Rs 439 Cr
Total expenditure (latest year)Rs 446 Cr
Total income (latest year)Rs 462 Cr
Share capitalRs 24 Cr
ReservesRs 77 Cr
Shareholders' fundsRs 101 Cr
Total assetsRs 232 Cr
Net blockRs 20 Cr
Capital work in progressRs 0 Cr
InvestmentsRs 12 Cr
ReceivablesRs 82 Cr
InventoryRs 75 Cr
Other liabilitiesRs 97 Cr
Shares outstanding (crore)24.97
Ownership
Promoter holding58.93% (+1.54 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 39.9 is at the 12th percentile of its own 3.3-year range
(median 126.4, low 24.7, high 397.9).
P/B 9.21 is at the 12th percentile (median 20.32).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 543828 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -2.5% | -2.8% | +0.3 pts |
| 1 month | -6.7% | -6.8% | +0.1 pts |
| 3 months | -0.7% | -7.6% | +6.9 pts |
| 3 years | +342.8% | +14.2% | +328.6 pts |
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was -199% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 15% of total assets in 2026 |
| explain | Share dilution Share count up 147% in a year, 152% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹174 Cr +20.1% vs Jun 2025.
Net profit ₹6 Cr +41.7%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Pidilite Industries Ltd | 148,809 | 56.2 | 31.0 % |
| Gujarat Fluorochemicals Ltd | 48,402 | 78.4 | 9.64 % |
| Navin Fluorine International Ltd | 42,255 | 53.1 | 21.0 % |
| Aether Industries Ltd | 23,226 | 96.8 | 11.9 % |
| Deepak Nitrite Ltd | 20,854 | 26.3 | 11.4 % |
| Atul Ltd | 17,614 | 22.1 | 14.9 % |
| Aarti Industries Ltd | 17,045 | 32.6 | 6.86 % |
| Fine Organic Industries Ltd | 15,759 | 36.0 | 21.5 % |
| BASF India Ltd | 14,871 | 24.0 | 14.5 % |
| Privi Speciality Chemicals Ltd | 14,084 | 40.3 | 22.3 % |
| Anupam Rasayan India Ltd | 13,409 | 76.8 | 7.38 % |
| Vinati Organics Ltd | 12,173 | 24.4 | 21.4 % |
| Elantas Beck India Ltd | 10,820 | 60.9 | 21.2 % |
| Jubilant Ingrevia Ltd | 10,180 | 32.0 | 11.4 % |
| Alkyl Amines Chemicals Ltd | 9,111 | 40.5 | 16.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd (543828) has a market capitalisation of Rs 933 Cr. at the 2026-10-01 close.
What is the P/E ratio of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd trades at a P/E of 37.1 on trailing twelve-month profit, at the 2026-10-01 close.
What were Sudarshan Pharma Industries Ltd's latest quarterly results?
In the Jun 2026 quarter, Sudarshan Pharma Industries Ltd sales was Rs 174 Cr (+20.1% vs Jun 2025) and net profit was Rs 6 Cr.